Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
To demonstrate the non-inferiority of the MyStar DoseCoach (Long-acting Insulin Glargine
Titration Meter) device-supported treat-to-target regimen relative to a routine titration
regimen in the percentage of patients reaching glycemic target, ie, with a mean fasting
self-monitored plasma glucose (FSMPG) value within the target range of 90-130 mg/dL (5.0-7.2
mmol/L) without a severe hypoglycemic episode during the 16-week on-treatment period.
Secondary Objective:
To assess the efficacy, safety, and adherence/satisfaction of MyStar DoseCoach